Vladimír Beneš1, Michal Zápotocký2, Petr Libý3, Jakub Táborský3, Jana Blažková4, Jana Blažková4, David Sumerauer2, Adéla Mišove2, Ivana Perníková5, Martin Kynčl6, Lenka Krsková7, Miroslav Koblížek7, Josef Zámečník7, Ondřej Bradáč3,8, Michal Tichý3. 1. Department of Neurosurgery, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, Prague, Czech Republic. vladimir.benes@fnmotol.cz. 2. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. 3. Department of Neurosurgery, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, Prague, Czech Republic. 4. Department of Anaesthesiology and Intensive Care Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. 5. Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. 6. Department of Radiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. 7. Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. 8. Department of Neurosurgery and Neurooncology, First Medical Faculty, Charles University and Military University Hospital, Prague, Czech Republic.
Abstract
BACKGROUND: Childhood thalamopeduncular gliomas arise at the interface of the thalamus and cerebral peduncle. The optimal treatment is total resection but not at the cost of neurological function. We present long-term clinical and oncological outcomes of maximal safe resection. METHODS: Retrospective review of prospectively collected data: demography, symptomatology, imaging, extent of resection, surgical complications, histology, functional and oncological outcome. RESULTS: During 16-year period (2005-2020), 21 patients were treated at our institution. These were 13 girls and 8 boys (mean age 7.6 years). Presentation included progressive hemiparesis in 9 patients, raised intracranial pressure in 9 patients and cerebellar symptomatology in 3 patients. The tumour was confined to the thalamus in 6 cases. Extent of resection was judged on postoperative imaging as total (6), near-total (6) and less extensive (9). Surgical complications included progression of baseline neurological status in 6 patients, and 5 of these gradually improved to preoperative status. All tumours were classified as low-grade gliomas. Disease progression was observed in 9 patients (median progression-free survival 7.3 years). At last follow-up (median 6.1 years), all patients were alive, median Lansky score of 90. Seven patients were without evidence of disease, 6 had stable disease, 7 stable following progression and 1 had progressive disease managed expectantly. CONCLUSION: Paediatric patients with low-grade thalamopeduncular gliomas have excellent long-term functional and oncological outcomes when gross total resection is not achievable. Surgery should aim at total resection; however, neurological function should not be endangered due to excellent chance for long-term survival.
BACKGROUND: Childhood thalamopeduncular gliomas arise at the interface of the thalamus and cerebral peduncle. The optimal treatment is total resection but not at the cost of neurological function. We present long-term clinical and oncological outcomes of maximal safe resection. METHODS: Retrospective review of prospectively collected data: demography, symptomatology, imaging, extent of resection, surgical complications, histology, functional and oncological outcome. RESULTS: During 16-year period (2005-2020), 21 patients were treated at our institution. These were 13 girls and 8 boys (mean age 7.6 years). Presentation included progressive hemiparesis in 9 patients, raised intracranial pressure in 9 patients and cerebellar symptomatology in 3 patients. The tumour was confined to the thalamus in 6 cases. Extent of resection was judged on postoperative imaging as total (6), near-total (6) and less extensive (9). Surgical complications included progression of baseline neurological status in 6 patients, and 5 of these gradually improved to preoperative status. All tumours were classified as low-grade gliomas. Disease progression was observed in 9 patients (median progression-free survival 7.3 years). At last follow-up (median 6.1 years), all patients were alive, median Lansky score of 90. Seven patients were without evidence of disease, 6 had stable disease, 7 stable following progression and 1 had progressive disease managed expectantly. CONCLUSION: Paediatric patients with low-grade thalamopeduncular gliomas have excellent long-term functional and oncological outcomes when gross total resection is not achievable. Surgery should aim at total resection; however, neurological function should not be endangered due to excellent chance for long-term survival.
Authors: S Jared Broadway; Robert J Ogg; Matthew A Scoggins; Robert Sanford; Zoltan Patay; Frederick A Boop Journal: J Neurosurg Pediatr Date: 2011-06 Impact factor: 2.375
Authors: Giuseppe Cinalli; Daniel T Aguirre; Giuseppe Mirone; Claudio Ruggiero; Daniele Cascone; Lucia Quaglietta; Ferdinando Aliberti; Serena De' Santi; Maria Consiglio Buonocore; Anna Nastro; Pietro Spennato Journal: J Neurosurg Pediatr Date: 2017-12-22 Impact factor: 2.375
Authors: Jason Fangusaro; Olaf Witt; Pablo Hernáiz Driever; Asim K Bag; Peter de Blank; Nadja Kadom; Lindsay Kilburn; Robert M Lober; Nathan J Robison; Michael J Fisher; Roger J Packer; Tina Young Poussaint; Ludmila Papusha; Shivaram Avula; Alba A Brandes; Eric Bouffet; Daniel Bowers; Anton Artemov; Murali Chintagumpala; David Zurakowski; Martin van den Bent; Brigitte Bison; Kristen W Yeom; Walter Taal; Katherine E Warren Journal: Lancet Oncol Date: 2020-06 Impact factor: 41.316
Authors: Emrah Celtikci; Pinar Celtikci; David Tiago Fernandes-Cabral; Murat Ucar; Juan Carlos Fernandez-Miranda; Alp Ozgun Borcek Journal: World Neurosurg Date: 2016-11-22 Impact factor: 2.104
Authors: Linda Douw; Martin Klein; Selene Saa Fagel; Josje van den Heuvel; Martin Jb Taphoorn; Neil K Aaronson; Tjeerd J Postma; W Peter Vandertop; Jacob J Mooij; Rudolf H Boerman; Guus N Beute; Jasper D Sluimer; Ben J Slotman; Jaap C Reijneveld; Jan J Heimans Journal: Lancet Neurol Date: 2009-08-07 Impact factor: 44.182
Authors: Pratiti Bandopadhayay; Guillaume Bergthold; Wendy B London; Liliana C Goumnerova; Andres Morales La Madrid; Karen J Marcus; Dongjing Guo; Nicole J Ullrich; Nathan J Robison; Susan N Chi; Rameen Beroukhim; Mark W Kieran; Peter E Manley Journal: Pediatr Blood Cancer Date: 2014-01-30 Impact factor: 3.167
Authors: Kyriakos Papadimitriou; Giulia Cossu; Ekkehard Hewer; Manuel Diezi; Roy Thomas Daniel; Mahmoud Messerer Journal: Children (Basel) Date: 2022-04-29